SCHEMBL31301334

SCHEMBL31301334

O=C(O)c1ncc(-c2ccc(Cl)cc2)o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.54
MAP4K4 O95819 1/20 0.54
HDAC1 Q13547 2/20 0.51
HDAC6 Q9UBN7 2/20 0.51
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
VCP P55072 1/20 0.47
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44
TUBA1B P68363 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL892926 0.84 TUBB4A (0.59) NOTUMHDAC1HDAC6NPC1RAB9A
SCHEMBL30301357 0.83 MAP4K4 (0.58) NOTUMMAP4K4HDAC1HDAC6NPC1
SCHEMBL19075477 0.83 NPC1 (0.58) HDAC1HDAC6NPC1RAB9ATUBB4A
SCHEMBL8141902 0.83 FAAH (0.56) HDAC1HDAC6NPC1RAB9ATUBB4A
SCHEMBL4790263 0.82 TUBB4A (0.57) NOTUMHDAC1HDAC6NPC1RAB9A
SCHEMBL31301388 0.82 PTPN1 (0.46) HDAC1HDAC6NPC1RAB9AHDAC3
SCHEMBL25207761 0.81 HDAC1 (0.56) MAP4K4HDAC1HDAC6NPC1RAB9A
SCHEMBL30975709 0.81 HDAC1 (0.56) MAP4K4HDAC1HDAC6NPC1RAB9A
SCHEMBL14192604 0.81 FAAH (0.50) HDAC1HDAC6NPC1RAB9ATUBB4A
SCHEMBL31301546 0.80 TUBB4A (0.67) NOTUMMAP4K4HDAC1HDAC6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727549-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS University of Georgia Research Foundation, Inc. (US) 2026-04-22 EP disclosed
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIV GEORGIA (US) 2026-04-09 US disclosed
WO-2024258900-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2024-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS SUB1, PFN1, HCCS NOTUM 3845/4885MAP4K4 4387/4885HDAC1 1273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.